Physician

Stephen Reintjes, M.D.

According to 2025 Medicare claims, Stephen Reintjes, M.D. (NPI: 1356630735) practices neurosurgery in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Clay, MO. This provider's primary affiliated billing organization is MERITAS HEALTH CORPORATION (NPI: 1285043794; TIN: 431639806) and primary practice location at 64116-3223. Reintjes is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Aledade 98 MO MSSP Enhanced (ACO ID: A4998), Centrus Health LLC (ACO ID: A5304), and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Reintjes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 621 traditional Medicare patients, billed 1,791 HCPCS/CPT codes, and received $492,584 in Medicare payments. The top billing code was 63047 (Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment). Part D data shows 2,319 prescription claims across 536 beneficiaries totaling $210,843 in drug costs, led by Forteo (Teriparatide). Open Payments data shows 27 records totaling $9,649. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $59,893 to $492,584. Similarly, Part D prescription costs have moved sharply higher in recent years, from $301 to $210,843. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	94	257	$59,893
2019	312	1,025	$255,251
2020	497	1,439	$402,877
2021	505	1,492	$398,132
2022	674	1,630	$375,612
2023	689	1,958	$529,680
2024	621	1,791	$492,584

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	21	$301
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	23	42	$479
2019	119	274	$5,757
2020	176	405	$14,593
2021	275	919	$79,848
2022	417	1,554	$65,572
2023	568	2,413	$118,013
2024	536	2,319	$210,843

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
63047	Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment	59	59	$732
22853	Insertion of cage or mesh device to spine bone and disc space during spine fusion	74	118	$201
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	216	216	$117
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	53	55	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	396	567	$92

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Forteo	Teriparatide	19	532	$80,223
Tymlos	Abaloparatide	30	900	$79,746
Teriparatide	Teriparatide	15	420	$31,731
Methocarbamol	Methocarbamol	537	15,661	$4,529
Gabapentin	Gabapentin	316	12,036	$4,006

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$9,649	Kuros Biosciences USA, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephen Reintjes, M.D.?

Tedicare shows public-source Medicare data for Stephen Reintjes, M.D. (NPI 1356630735), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Reintjes, M.D. have ACO affiliation data?

Stephen Reintjes, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998), Centrus Health LLC (MSSP, ACO ID A5304), and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Stephen Reintjes, M.D.?

Stephen Reintjes, M.D. is linked to MERITAS HEALTH CORPORATION (billing NPI 1285043794) in the available physician profile data.

Does Stephen Reintjes, M.D. have Open Payments data?

Stephen Reintjes, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.